Alice Han1, Donna E Stewart2. 1. Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada. 2. Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; University Health Network, Toronto, Canada. Electronic address: donna.stewart@uhn.ca.
Abstract
BACKGROUND: Very high rates of intimate partner violence during pregnancy (IPV-P) are reported in Latin America and the Caribbean (LAC) but data on prevalence and obstetric-related outcomes are limited. OBJECTIVES: To conduct a literature review on risk factors, prevalence, and adverse obstetric-related outcomes of IPV-P in LAC. SEARCH STRATEGY: Systematic review of studies in MEDLINE (1946-2012) and LILACS (1982-2012), and hand searching of reference lists of included studies. Search terms were variations of partner abuse and pregnancy in LAC. SELECTION CRITERIA: Studies were excluded if they did not include IPV-P prevalence or if the perpetrator was not an intimate partner. DATA COLLECTION AND ANALYSIS: Study quality was assessed via US Preventive Services Task Force criteria. MAIN RESULTS: In the 31 studies included, prevalence rates ranged from 3% to 44%. IPV-P was significantly associated with unintended pregnancies and adverse maternal (depression, pregnancy-related symptom distress, inadequate prenatal care, vaginal bleeding, spontaneous abortion, gestational weight gain, high maternal cortisol, hypertension, pre-eclampsia, STIs) and infant (prematurity, low birth weight, neonatal complications, stillbirth) outcomes (grade II-2 and 3 evidence). CONCLUSIONS: IPV-P is highly prevalent in LAC, with poor obstetric-related outcomes. Clinicians must identify women experiencing IPV-P and institute appropriate interventions and referrals to avoid its deleterious consequences.
BACKGROUND: Very high rates of intimate partner violence during pregnancy (IPV-P) are reported in Latin America and the Caribbean (LAC) but data on prevalence and obstetric-related outcomes are limited. OBJECTIVES: To conduct a literature review on risk factors, prevalence, and adverse obstetric-related outcomes of IPV-P in LAC. SEARCH STRATEGY: Systematic review of studies in MEDLINE (1946-2012) and LILACS (1982-2012), and hand searching of reference lists of included studies. Search terms were variations of partner abuse and pregnancy in LAC. SELECTION CRITERIA: Studies were excluded if they did not include IPV-P prevalence or if the perpetrator was not an intimate partner. DATA COLLECTION AND ANALYSIS: Study quality was assessed via US Preventive Services Task Force criteria. MAIN RESULTS: In the 31 studies included, prevalence rates ranged from 3% to 44%. IPV-P was significantly associated with unintended pregnancies and adverse maternal (depression, pregnancy-related symptom distress, inadequate prenatal care, vaginal bleeding, spontaneous abortion, gestational weight gain, high maternal cortisol, hypertension, pre-eclampsia, STIs) and infant (prematurity, low birth weight, neonatal complications, stillbirth) outcomes (grade II-2 and 3 evidence). CONCLUSIONS: IPV-P is highly prevalent in LAC, with poor obstetric-related outcomes. Clinicians must identify women experiencing IPV-P and institute appropriate interventions and referrals to avoid its deleterious consequences.
Authors: Bizu Gelaye; Ngan Do; Samantha Avila; Juan Carlos Velez; Qiu-Yue Zhong; Sixto E Sanchez; B Lee Peterlin; Michelle A Williams Journal: Headache Date: 2016-05-31 Impact factor: 5.887
Authors: Erick Forno; Mudita Gogna; Alfonso Cepeda; Anahi Yañez; Dirceu Solé; Philip Cooper; Lydiana Avila; Manuel Soto-Quiros; Jose A Castro-Rodriguez; Juan C Celedón Journal: Thorax Date: 2015-06-23 Impact factor: 9.139
Authors: Donna E Stewart; Simone N Vigod; Harriet L MacMillan; Prabha S Chandra; Alice Han; Marta B Rondon; Jennifer C D MacGregor; Ekaterina Riazantseva Journal: Curr Psychiatry Rep Date: 2017-05 Impact factor: 5.285
Authors: Maria José Rosa; Allan C Just; Marcela Tamayo Y Ortiz; Lourdes Schnaas; Katherine Svensson; Robert O Wright; Martha María Téllez Rojo; Rosalind J Wright Journal: Ann Allergy Asthma Immunol Date: 2016-01-25 Impact factor: 6.347